STRONG BONES
About STRONG BONES
Participants in the STRONG BONES study are 40 years of age and older and scheduled to undergo a sleeve gastrectomy through the Wake Forest Weight Management Center. Patients will be randomized to receive either the study drug, Risedronate, or a placebo for six months. Changes in bone density with post-surgical weight loss will be measured and compared.
You may qualify to participate if you are:
- Planning to have a sleeve gastrectomy
- 40 years of age or older at the time of surgery
Complete this brief survey to see if you may qualify to participate!
To learn more about the study, please call 336.758.4078 or email strongbones@wfu.edu.
Strategies to Reduce the Onset of Sleeve Gastrectomy Associated Bone Loss (STRONG BONES)
- Awarding Agency: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
- Funding Source: National Institutes of Health (NIH)
- Principal Investigator(s): Kristen M. Beavers, PhD; Jamy D. Ard, MD
- Co-investigators: Adolfo Fernandez, MD; Daniel Beavers, PhD; Ashley Weaver, PhD; Philip Kramer, PhD